Bioequivalence study of entacapone tablets (0.2g) in healthy trial participants (chinadrugtrials.org.cn) - Oct 8, 2026 - P=N/A | N=40 | Not yet recruiting | Sponsor: Wuhan Humanwell Pharmaceutical Co., Ltd.
New trial • CNS Disorders • Movement Disorders • Parkinson's Disease
|